Sirong Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sirong Shi has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Yunfeng Lin
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China
8 shared publications - Weitong Lu
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China
4 shared publications Yang Chen
Department of Pediatric Surgery, Department of Liver Surgery & Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China
4 shared publicationsYunfeng Lin
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China; Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu, Sichuan 610041, China
4 shared publicationsMi Zhou
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
3 shared publications- Ruijianghan Shi
Department of Oral and Craniomaxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China
3 shared publications
Latest Publications
- 14 September 2026
- Published by Springer Nature in Science China Chemistry
- Vol. 69 (11) , 6239-6272
Multifunctional nucleic acid-based therapy in fibrosis-related diseases
- 14 September 2026
- Published by Springer Nature in Science China Chemistry
- Vol. 69 (11) , 6239-6272
Multifunctional nucleic acid-based therapy in fibrosis-related diseases
- 10 September 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (34) , 18456-18467
Tetrahedral framework nucleic acids loaded with microRNA-17 for treating temporomandibular joint osteoarthritis: mechanisms of action
Schematic of TM17 : tFNAs assembled from four ssDNAs conjugated with sticky-end miR17 (cmiR17) enter IL-1β-induced inflamed chondrocytes, inhibit inflammation and restore cartilage matrix, enabling nucleic acid therapy for TMJOA.
- 10 September 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (34) , 18456-18467
Tetrahedral framework nucleic acids loaded with microRNA-17 for treating temporomandibular joint osteoarthritis: mechanisms of action
Schematic of TM17 : tFNAs assembled from four ssDNAs conjugated with sticky-end miR17 (cmiR17) enter IL-1β-induced inflamed chondrocytes, inhibit inflammation and restore cartilage matrix, enabling nucleic acid therapy for TMJOA.
- 6 January 2026
- Published by Springer Nature in Science China Materials
- Vol. 69 (3) , 1786-1796
Tetrahedral framework nucleic acid loaded celastrol ameliorates skin fibrosis by epithelial-mesenchymal transition prevention
- 6 January 2026
- Published by Springer Nature in Science China Materials
- Vol. 69 (3) , 1786-1796
Tetrahedral framework nucleic acid loaded celastrol ameliorates skin fibrosis by epithelial-mesenchymal transition prevention
- Open Access
- 21 December 2025
- Published by Elsevier in Materials Today Bio
- Vol. 36, 102708
Functional nucleic acid Hydrogels: Paving the way for Next-generation bone and cartilage regeneration
- 21 December 2025
- Published by Elsevier in Materials Today Bio
- Vol. 36, 102708
Open AccessFunctional nucleic acid Hydrogels: Paving the way for Next-generation bone and cartilage regeneration
- Top Cited PapersOpen Access
- 7 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (26) , e2502661
Cartilage‐Penetrating Framework Nucleic Acid Nanoparticles Ameliorate Osteoarthritis by Promoting Drug Delivery and Chondrocyte Uptake
Osteoarthritis (OA) is a chronic joint disease that causes a gradual deterioration of articular cartilage. A major challenge in OA treatment is the limited penetration and delivery efficiency of drugs to cartilage and chondrocytes due to the rapid clearance of drugs through synovial fluid in joints and the osmotic barrier of the cartilage extracellular matrix (ECM). To address this issue, a novel tetrahedral framework nucleic acid (tFNA)‐based nanomedicine delivery system (tFNA‐2WL) is first synthesized with excellent cartilage permeability and perfect chondrocyte endocytosis properties. After being loaded with ginsenoside Rb1 (Gin), the tFNA‐2WL&Gin complex not only penetrates the cartilage but also accumulates in the menisci, ligaments, and joint capsules, thus prolonging the residence time of Gin in OA rat knees. In vitro, tFNA‐2WL&Gin effectively promotes chondrogenesis, inhibits cartilage degradation by reducing apoptosis, and scavenges reactive oxygen species (ROS), outperforming free Gin. In OA rats, tFNA‐2WL&Gin restores gait, reduces osteophyte formation, inhibits synovial inflammation and hypertrophy, and protects cartilage from further damage more effectively than Gin and other nanomedicines. These results demonstrate the feasibility of tFNA‐2WL in improving the pharmacokinetics and efficacy of drugs and highlight the favorable curative effects of tFNA‐2WL&Gin for OA, offering a promising paradigm for translational medicine.
- 7 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (26) , e2502661
Top Cited PapersOpen AccessCartilage‐Penetrating Framework Nucleic Acid Nanoparticles Ameliorate Osteoarthritis by Promoting Drug Delivery and Chondrocyte Uptake
Osteoarthritis (OA) is a chronic joint disease that causes a gradual deterioration of articular cartilage. A major challenge in OA treatment is the limited penetration and delivery efficiency of drugs to cartilage and chondrocytes due to the rapid clearance of drugs through synovial fluid in joints and the osmotic barrier of the cartilage extracellular matrix (ECM). To address this issue, a novel tetrahedral framework nucleic acid (tFNA)‐based nanomedicine delivery system (tFNA‐2WL) is first synthesized with excellent cartilage permeability and perfect chondrocyte endocytosis properties. After being loaded with ginsenoside Rb1 (Gin), the tFNA‐2WL&Gin complex not only penetrates the cartilage but also accumulates in the menisci, ligaments, and joint capsules, thus prolonging the residence time of Gin in OA rat knees. In vitro, tFNA‐2WL&Gin effectively promotes chondrogenesis, inhibits cartilage degradation by reducing apoptosis, and scavenges reactive oxygen species (ROS), outperforming free Gin. In OA rats, tFNA‐2WL&Gin restores gait, reduces osteophyte formation, inhibits synovial inflammation and hypertrophy, and protects cartilage from further damage more effectively than Gin and other nanomedicines. These results demonstrate the feasibility of tFNA‐2WL in improving the pharmacokinetics and efficacy of drugs and highlight the favorable curative effects of tFNA‐2WL&Gin for OA, offering a promising paradigm for translational medicine.
- 16 December 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (9) , 4974-4999
Multifunctional DNA nanomaterials: a new frontier in rheumatoid arthritis diagnosis and treatment
DNA nanomaterials offer promising advancements in addressing the challenges of rheumatoid arthritis (RA) through targeted drug delivery, biomarker detection, and therapeutic innovation.
- 16 December 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (9) , 4974-4999
Multifunctional DNA nanomaterials: a new frontier in rheumatoid arthritis diagnosis and treatment
DNA nanomaterials offer promising advancements in addressing the challenges of rheumatoid arthritis (RA) through targeted drug delivery, biomarker detection, and therapeutic innovation.
- Open Access
- 1 October 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 40, 634-648
A novel mesenchymal stem cell-targeting dual-miRNA delivery system based on aptamer-functionalized tetrahedral framework nucleic acids: Application to endogenous regeneration of articular cartilage
Articular cartilage injury (ACI) remains one of the key challenges in regenerative medicine, as current treatment strategies do not result in ideal regeneration of hyaline-like cartilage. Enhancing endogenous repair via microRNAs (miRNAs) shows promise as a regenerative therapy. miRNA-140 and miRNA-455 are two key and promising candidates for regulating the chondrogenic differentiation of mesenchymal stem cells (MSCs). In this study, we innovatively synthesized a multifunctional tetrahedral framework in which a nucleic acid (tFNA)-based targeting miRNA codelivery system, named A-T-M, was used. With tFNAs as vehicles, miR-140 and miR-455 were connected to and modified on tFNAs, while Apt19S (a DNA aptamer targeting MSCs) was directly integrated into the nanocomplex. The relevant results showed that A-T-M efficiently delivered miR-140 and miR-455 into MSCs and subsequently regulated MSC chondrogenic differentiation through corresponding mechanisms. Interestingly, a synergistic effect between miR-140 and miR-455 was revealed. Furthermore, A-T-M successfully enhanced the endogenous repair capacity of articular cartilage in vivo and effectively inhibited hypertrophic chondrocyte formation. A-T-M provides a new perspective and strategy for the regeneration of articular cartilage, showing strong clinical application value in the future treatment of ACI.
- 1 October 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 40, 634-648
Open AccessA novel mesenchymal stem cell-targeting dual-miRNA delivery system based on aptamer-functionalized tetrahedral framework nucleic acids: Application to endogenous regeneration of articular cartilage
Articular cartilage injury (ACI) remains one of the key challenges in regenerative medicine, as current treatment strategies do not result in ideal regeneration of hyaline-like cartilage. Enhancing endogenous repair via microRNAs (miRNAs) shows promise as a regenerative therapy. miRNA-140 and miRNA-455 are two key and promising candidates for regulating the chondrogenic differentiation of mesenchymal stem cells (MSCs). In this study, we innovatively synthesized a multifunctional tetrahedral framework in which a nucleic acid (tFNA)-based targeting miRNA codelivery system, named A-T-M, was used. With tFNAs as vehicles, miR-140 and miR-455 were connected to and modified on tFNAs, while Apt19S (a DNA aptamer targeting MSCs) was directly integrated into the nanocomplex. The relevant results showed that A-T-M efficiently delivered miR-140 and miR-455 into MSCs and subsequently regulated MSC chondrogenic differentiation through corresponding mechanisms. Interestingly, a synergistic effect between miR-140 and miR-455 was revealed. Furthermore, A-T-M successfully enhanced the endogenous repair capacity of articular cartilage in vivo and effectively inhibited hypertrophic chondrocyte formation. A-T-M provides a new perspective and strategy for the regeneration of articular cartilage, showing strong clinical application value in the future treatment of ACI.
- 8 September 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 375, 155-177
Advances in DNA nanotechnology for chronic wound management: Innovative functional nucleic acid nanostructures for overcoming key challenges
- 8 September 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 375, 155-177
Advances in DNA nanotechnology for chronic wound management: Innovative functional nucleic acid nanostructures for overcoming key challenges
- Open Access
- 29 August 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (38) , 27904-27927
Nanomaterials: innovative approaches for addressing key objectives in periodontitis treatment
Periodontitis is a chronic inflammatory disease primarily caused by dental plaque, which is a significant global public health concern due to its high prevalence and severe impact on oral, and even systemic diseases.
- 29 August 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (38) , 27904-27927
Open AccessNanomaterials: innovative approaches for addressing key objectives in periodontitis treatment
Periodontitis is a chronic inflammatory disease primarily caused by dental plaque, which is a significant global public health concern due to its high prevalence and severe impact on oral, and even systemic diseases.